Abstract
Spinal and bulbar muscular atrophy is caused by polyglutamine expansion in the androgen receptor. As an X-linked disease dependent on androgens, symptoms and findings are only fully manifest in males. Here we describe a 40-year-old male-to-female transgender SBMA patient who developed full disease manifestations despite undetectable levels of androgens. We used cell culture and animal models to show that spironolactone, the anti-androgen she had taken for 15 years, promotes nuclear localization and toxicity of the mutant protein, which may explain the disease manifestations in this patient.
Original language | English (US) |
---|---|
Pages (from-to) | 121-125 |
Number of pages | 5 |
Journal | Journal of neuromuscular diseases |
Volume | 3 |
Issue number | 1 |
DOIs | |
State | Published - 2016 |
Keywords
- Motor neuron disease
- X-Linked
- androgen
- bulbo-spinal atrophy
- receptors
- spironolactone
ASJC Scopus subject areas
- Clinical Neurology
- Neurology